LITAK sol inj 10 mg/5ml 5 flac 5 ml
7680551720133
CH-55172
L01BB04
07.16.1.
Reimbursement limitations:
LITAK
LITAK 10 est remboursé exclusivement pour le traitement de la leucémie à tricholeucocytes.
1 / 3
google
Details
- Product number
- 5517201
- CPT
- -
- Packaging group
- 5
- Unit
- Durchstechflasche(n)
- Composition
- cladribinum 10 mg, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium max. 17.84 mg.
Articles (1)
Litak 10, Injektions- / Infusionslösung
Infusionslösung
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 1651.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2024
Authorization holder
Lipomed AG
4144 Arlesheim
Authorization information
- Swissmedic authorization number
- 55172
- Drug name
- Litak 10, Injektions- / Infusionslösung
- Galenic form
- LSIN
- ATC Code
- L01BB04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 03/11/1999
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LITAK sol inj 10 mg/5ml 5 flac 5 ml
- Description (DE)
- LITAK Inj Lös 10 mg/5ml 5 Durchstf 5 ml
- Market launch
- 03/11/1999
- Narcotic (BTM)
- No